D

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017

Watchlist Manager
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Watchlist
Price: 58.2 SAR 1.93% Market Closed
Market Cap: 13.5B SAR
Have any thoughts about
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC?
Write Note

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Revenue
ď·Ľ2.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dallah Healthcare Company SJSC
SAU:4004
Revenue
ď·Ľ3.1B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
14%
National Medical Care Company JSC
SAU:4005
Revenue
ď·Ľ1.2B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
6%
Mouwasat Medical Services Company SJSC
SAU:4002
Revenue
ď·Ľ2.8B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
12%
A
Al Hammadi Holding Co
SAU:4007
Revenue
ď·Ľ1.1B
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
9%
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Revenue
ď·Ľ9.5B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View

Market Cap
13.5B SAR
Industry
Health Care

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a SA-based company operating in Health Care Providers & Services industry. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. Dr. Soliman Fakeeh Hospital (DSFH) is a Saudi Arabia-based company. The firm is engaged in operating private hospitals and clinics. The company offers its medical services through six units: the Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.

Intrinsic Value
42.29 SAR
Overvaluation 27%
Intrinsic Value
Price
D

See Also

What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Revenue?
Revenue
2.3B SAR

Based on the financial report for Dec 31, 2023, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Revenue amounts to 2.3B SAR.

What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Revenue growth rate?
Revenue CAGR 1Y
16%

Over the last year, the Revenue growth was 16%.

Back to Top